3 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Adenosine Monophosphate: new trials by email Literature Review of Adenosine Monophosphate trials Research Report on Adenosine Monophosphate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) MMRV (AMP), MMRV (2006 process) - Measles, Mumps | Phase 3 | Completed | Merck Sharp & Dohme LLC | 1412 | 2012-06-05 | 2018-10-31 |
| Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1) Zoster Vaccine, Live (AMP), Zoster Vaccine, Live - Herpes Zoster, Shingles | Phase 3 | Completed | Merck Sharp & Dohme LLC | 498 | 2012-04-01 | 2017-04-12 |
| Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT), NNRTIs (EFV, NVP), PIs (AMP, IDV, LPV/r, NFV, SQV, RTV) - HIV Infections | Phase 2 / Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 266 | 2002-08-01 | 2021-11-05 |
Chickenpox (1) · HIV Infections (1) · Herpes Zoster (1) · Measles (1) · Mumps (1) · Rubella (1)
Merck Sharp & Dohme LLC (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Puerto Rico (1) · United States (1)
Ann J. Melvin, MD (1) · Ross E. McKinney, Jr., MD (1)